N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide

C172H184Cl3N47O17 — CID 158262599

IUPACN-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide
SMILESCC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.CC(C)NC(=O)N1CCc2cc(-c3nc(Cc4ccc5[nH]ncc5c4Cl)n(C)n3)ccc2C1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC(C)C.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC1CNC1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1CNC(C)=O.COc1cc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C
InChIInChI=1S/C27H27N7O3.C26H30ClN7O3.C26H25N7O2.C24H26ClN7O.C24H27N7O3.C24H28N6O3.C21H21ClN6O2/c1-17(2)30-26(35)16-37-22-10-8-19(14-23(22)36-3)27-33-32-25(34(27)24-6-4-5-11-28-24)13-18-7-9-21-20(12-18)15-29-31-21;1-16(2)29-24(35)15-37-22-7-5-18(12-21(22)34-8-10-36-11-9-34)26-30-23(33(3)32-26)13-17-4-6-20-19(25(17)27)14-28-31-20;1-17(2)29-25(34)16-35-21-9-7-19(8-10-21)26-32-31-24(33(26)23-5-3-4-12-27-23)14-18-6-11-22-20(13-18)15-28-30-22;1-14(2)27-24(33)32-9-8-15-10-17(4-5-18(15)13-32)23-28-21(31(3)30-23)11-16-6-7-20-19(22(16)25)12-26-29-20;1-14-15(4-6-19-18(14)12-26-29-19)9-22-28-24(30-31(22)2)16-5-7-20(21(8-16)33-3)34-13-23(32)27-17-10-25-11-17;1-14(2)26-23(31)13-33-20-9-7-17(10-21(20)32-5)24-27-22(30(4)29-24)11-16-6-8-19-18(15(16)3)12-25-28-19;1-12(29)23-10-15-5-4-14(8-18(15)30-3)21-25-19(28(2)27-21)9-13-6-7-17-16(20(13)22)11-24-26-17/h4-12,14-15,17H,13,16H2,1-3H3,(H,29,31)(H,30,35);4-7,12,14,16H,8-11,13,15H2,1-3H3,(H,28,31)(H,29,35);3-13,15,17H,14,16H2,1-2H3,(H,28,30)(H,29,34);4-7,10,12,14H,8-9,11,13H2,1-3H3,(H,26,29)(H,27,33);4-8,12,17,25H,9-11,13H2,1-3H3,(H,26,29)(H,27,32);6-10,12,14H,11,13H2,1-5H3,(H,25,28)(H,26,31);4-8,11H,9-10H2,1-3H3,(H,23,29)(H,24,26)
InChIKeyGIAYPYFBPGWURX-UHFFFAOYSA-N
MW3288.03 g/mol
LogP22.98
Rot. Bonds51

About N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide

N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide (PubChem CID 158262599) has the molecular formula C172H184Cl3N47O17 and a molecular weight of 3288.03 g/mol. Its IUPAC name is N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide.

Molecular Properties

Compound NameN-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide
PubChem CID158262599
Molecular FormulaC172H184Cl3N47O17
Molecular Weight3288.03 g/mol
Exact Mass3284.40
IUPAC NameN-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide
SMILESCC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.CC(C)NC(=O)N1CCc2cc(-c3nc(Cc4ccc5[nH]ncc5c4Cl)n(C)n3)ccc2C1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC(C)C.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC1CNC1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1CNC(C)=O.COc1cc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C
InChIInChI=1S/C27H27N7O3.C26H30ClN7O3.C26H25N7O2.C24H26ClN7O.C24H27N7O3.C24H28N6O3.C21H21ClN6O2/c1-17(2)30-26(35)16-37-22-10-8-19(14-23(22)36-3)27-33-32-25(34(27)24-6-4-5-11-28-24)13-18-7-9-21-20(12-18)15-29-31-21;1-16(2)29-24(35)15-37-22-7-5-18(12-21(22)34-8-10-36-11-9-34)26-30-23(33(3)32-26)13-17-4-6-20-19(25(17)27)14-28-31-20;1-17(2)29-25(34)16-35-21-9-7-19(8-10-21)26-32-31-24(33(26)23-5-3-4-12-27-23)14-18-6-11-22-20(13-18)15-28-30-22;1-14(2)27-24(33)32-9-8-15-10-17(4-5-18(15)13-32)23-28-21(31(3)30-23)11-16-6-7-20-19(22(16)25)12-26-29-20;1-14-15(4-6-19-18(14)12-26-29-19)9-22-28-24(30-31(22)2)16-5-7-20(21(8-16)33-3)34-13-23(32)27-17-10-25-11-17;1-14(2)26-23(31)13-33-20-9-7-17(10-21(20)32-5)24-27-22(30(4)29-24)11-16-6-8-19-18(15(16)3)12-25-28-19;1-12(29)23-10-15-5-4-14(8-18(15)30-3)21-25-19(28(2)27-21)9-13-6-7-17-16(20(13)22)11-24-26-17/h4-12,14-15,17H,13,16H2,1-3H3,(H,29,31)(H,30,35);4-7,12,14,16H,8-11,13,15H2,1-3H3,(H,28,31)(H,29,35);3-13,15,17H,14,16H2,1-2H3,(H,28,30)(H,29,34);4-7,10,12,14H,8-9,11,13H2,1-3H3,(H,26,29)(H,27,33);4-8,12,17,25H,9-11,13H2,1-3H3,(H,26,29)(H,27,32);6-10,12,14H,11,13H2,1-5H3,(H,25,28)(H,26,31);4-8,11H,9-10H2,1-3H3,(H,23,29)(H,24,26)
InChIKeyGIAYPYFBPGWURX-UHFFFAOYSA-N
XLogP22.98
TPSA756.02 Ų
H-Bond Donors15
H-Bond Acceptors49
Rotatable Bonds51
Heavy Atoms239
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003288.03
LogP ≤ 522.98
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1049

Analyze N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide?
The IUPAC name of N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide (CID 158262599) is N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide.
What is the SMILES notation for N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide?
The canonical SMILES for N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide is CC(C)NC(=O)COc1ccc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.CC(C)NC(=O)N1CCc2cc(-c3nc(Cc4ccc5[nH]ncc5c4Cl)n(C)n3)ccc2C1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC(C)C.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3C)n(C)n2)ccc1OCC(=O)NC1CNC1.COc1cc(-c2nc(Cc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1CNC(C)=O.COc1cc(-c2nnc(Cc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C.
What is the InChIKey of N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide?
The InChIKey is GIAYPYFBPGWURX-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27N7O3.C26H30ClN7O3.C26H25N7O2.C24H26ClN7O.C24H27N7O3.C24H28N6O3.C21H21ClN6O2/c1-17(2)30-26(35)16-37-22-10-8-19(14-23(22)36-3)27-33-32-25(34(27)24-6-4-5-11-28-24)13-18-7-9-21-20(12-18)15-29-31-21;1-16(2)29-24(35)15-37-22-7-5-18(12-21(22)34-8-10-36-11-9-34)26-30-23(33(3)32-26)13-17-4-6-20-19(25(17)27)14-28-31-20;1-17(2)29-25(34)16-35-21-9-7-19(8-10-21)26-32-31-24(33(26)23-5-3-4-12-27-23)14-18-6-11-22-20(13-18)15-28-30-22;1-14(2)27-24(33)32-9-8-15-10-17(4-5-18(15)13-32)23-28-21(31(3)30-23)11-16-6-7-20-19(22(16)25)12-26-29-20;1-14-15(4-6-19-18(14)12-26-29-19)9-22-28-24(30-31(22)2)16-5-7-20(21(8-16)33-3)34-13-23(32)27-17-10-25-11-17;1-14(2)26-23(31)13-33-20-9-7-17(10-21(20)32-5)24-27-22(30(4)29-24)11-16-6-8-19-18(15(16)3)12-25-28-19;1-12(29)23-10-15-5-4-14(8-18(15)30-3)21-25-19(28(2)27-21)9-13-6-7-17-16(20(13)22)11-24-26-17/h4-12,14-15,17H,13,16H2,1-3H3,(H,29,31)(H,30,35);4-7,12,14,16H,8-11,13,15H2,1-3H3,(H,28,31)(H,29,35);3-13,15,17H,14,16H2,1-2H3,(H,28,30)(H,29,34);4-7,10,12,14H,8-9,11,13H2,1-3H3,(H,26,29)(H,27,33);4-8,12,17,25H,9-11,13H2,1-3H3,(H,26,29)(H,27,32);6-10,12,14H,11,13H2,1-5H3,(H,25,28)(H,26,31);4-8,11H,9-10H2,1-3H3,(H,23,29)(H,24,26).
What are the key properties of N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide?
N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide has a molecular weight of 3288.03 g/mol, XLogP of 22.98, 51 rotatable bonds, 15 hydrogen bond donors, and 49 hydrogen bond acceptors.
Where does this data come from?
All data for N-(azetidin-3-yl)-2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]acetamide;N-[[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenyl]methyl]acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;6-[5-[(4-chloro-1H-indazol-5-yl)methyl]-1-methyl-1,2,4-triazol-3-yl]-N-propan-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylmethyl)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;2-[2-methoxy-4-[1-methyl-5-[(4-methyl-1H-indazol-5-yl)methyl]-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide is sourced from PubChem (CID 158262599), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).